Cargando…
Characterization of Salivary and Plasma Metabolites as Biomarkers for HCC: A Pilot Study
SIMPLE SUMMARY: Hepatocellular carcinoma is diagnosed using ultrasound and blood-biomarker AFP, which can miss up to 40% of diagnoses, delaying the treatment of these patients. The aim of our study was to identify metabolites that are associated with HCC in blood and saliva, and compare the metaboli...
Autores principales: | Hershberger, Courtney E., Raj, Roma, Mariam, Arshiya, Aykun, Nihal, Allende, Daniela S., Brown, Mark, Aucejo, Federico, Rotroff, Daniel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527521/ https://www.ncbi.nlm.nih.gov/pubmed/37760495 http://dx.doi.org/10.3390/cancers15184527 |
Ejemplares similares
-
Salivary miRNAs as non-invasive biomarkers of hepatocellular carcinoma: a pilot study
por: Mariam, Arshiya, et al.
Publicado: (2022) -
Immunotherapy Plus Locoregional Therapy Leading to Curative-Intent Hepatectomy in HCC: Proof of Concept Producing Durable Survival Benefits Detectable with Liquid Biopsy
por: Raj, Roma, et al.
Publicado: (2023) -
Breath Metabolomics Provides an Accurate and Noninvasive Approach for Screening Cirrhosis, Primary, and Secondary Liver Tumors
por: Miller‐Atkins, Galen, et al.
Publicado: (2020) -
Effects of Denture Treatment on Salivary Metabolites: A Pilot Study
por: Ichigaya, Narumi, et al.
Publicado: (2023) -
Identification of robust deep neural network models of longitudinal clinical measurements
por: Javidi, Hamed, et al.
Publicado: (2022)